您的位置: 首页 > 农业专利 > 详情页

HIGH-THROUGHPUT IDENTIFICATION OF PATIENT-SPECIFIC NEOEPITOPES AS THERAPEUTIC TARGETS FOR CANCER IMMUNOTHERAPIES.
专利权人:
NANTOMICS; LLC
发明人:
Patrick SOON-SHIONG,Andrew NGUYEN,Kayvan NIAZI,Shahrooz RABIZADEH,Stephen Charles BENZ,John Zachary SANBORN,Charles Joseph VASKE
申请号:
MX2018009804
公开号:
MX2018009804A
申请日:
2017.02.10
申请国别(地区):
MX
年份:
2018
代理人:
摘要:
Systems and methods are presented that allow for selection of tumor neoepitopes that are filtered for various criteria. In particularly contemplated aspects, filtering includes a step in which the mutation leading to the neoepitope is ascertained as being located in a cancer driver gene.Se presentan sistemas y métodos que permiten la selección de neoepítopos tumorales que se filtran según diversos criterios. En aspectos particularmente contemplados, la filtración incluye un paso en el que se determina que la mutación que conduce al neoepítopo está localizada en un gen controlador de cáncer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充